Market Newsdesk

BOCA RATON, Fla., April 04, 2025 (GLOBE NEWSWIRE) — FOREWARN, LLC, a red violet company (NASDAQ: RDVT) and the leading provider of real-time information solutions for real estate agents, today announced that Little Rock REALTORS^® Association (“LRRA”) will offer FOREWARN^® services to its 1,400+ members it serves throughout the Little Rock metropolitan area to promote proactive real estate agent safety.

Available both online and through a mobile application, FOREWARN analyzes billions of data points and provides users with the ability to mitigate risks by verifying identity, searching for criminal histories, and validating information provided by potential clients — using just a phone number. FOREWARN allows agents to properly and safely plan for showings with a higher level of confidence.

The FOREWARN services offered by LRRA are available to the 1,400+ members at no additional cost to individual agents.

“It’s exciting that my home Association has made this investment into the safety of our members,” stated Carl Carter, a Little Rock REALTORS^® Association member. “As a community still shaken by the tragic loss of my mom, Beverly Carter, providing access to FOREWARN further empowers agents to conduct their business in the safest way possible. I’ve been a FOREWARN user for several years now and have seen firsthand its transformative impact on how agents conduct their business and reinforcing the importance of consistent, informed workflows. As I’ve traveled the country speaking on agent safety, I’ve heard many stories from agents expressing gratitude for FOREWARN providing information they believe helped keep them safe. I’m so thankful the Little Rock REALTOR Association has brought this amazing resource to our agent family.”

Stacy Hamilton, CEO of Little Rock REALTORS^® Association, added “Our top priority is ensuring the safety and success of our members by providing them with the most effective tools available. With the ever-present risks in the industry, providing FOREWARN was a clear choice. Having instant access to advanced identity verification empowers our members to make informed decisions, enhancing both their security and confidence in every interaction.”

Existing LRRA members will receive specific instructions on how to move forward with activating their FOREWARN subscription as an included benefit.

All other real estate agencies, agents, and appraisers can learn more about FOREWARN at www.forewarn.com.

About FOREWARN^®

At FOREWARN, we bring instant knowledge through innovative solutions to ensure safer engagements and smarter interactions. Leveraging powerful analytics and a massive data repository, our solutions enable organizations to gain real-time knowledge, for purposes such as verifying identity, searching for criminal histories, and validating information. Risk assessment and due diligence at your fingertips™.

RELATED LINKS:

www.forewarn.com

About red violet^®

At red violet, we build proprietary technologies and apply analytical capabilities to deliver identity intelligence. Our technology powers critical solutions, which empower organizations to operate with confidence. Our solutions enable the real-time identification and location of people, businesses, assets and their interrelationships. These solutions are used for purposes including identity verification, risk mitigation, due diligence, fraud detection and prevention, regulatory compliance, and customer acquisition. Our intelligent platform, CORE™, is purpose-built for the enterprise, yet flexible enough for organizations of all sizes, bringing clarity to massive datasets by transforming data into intelligence. Our solutions are used today to enable frictionless commerce, to ensure safety, and to reduce fraud and the concomitant expense borne by society. For more information, please visit www.redviolet.com.

FORWARD-LOOKING STATEMENTS

This press release contains “forward-looking statements,” as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA), which statements may be identified by words such as “expects,” “plans,” “projects,” “will,” “may,” “anticipate,” “believes,” “should,” “intends,” “estimates,” and other words of similar meaning. Such forward looking statements are subject to risks and uncertainties that are often difficult to predict, are beyond our control and which may cause results to differ materially from expectations, including whether FOREWARN will address critical safety and security areas for Little Rock REALTORS^® Association members and whether FOREWARN will give Little Rock REALTORS^® Association members to make informed decisions, enhancing both their security and confidence in every interaction. Readers are cautioned not to place undue reliance on these forward-looking statements, which are based on our expectations as of the date of this press release and speak only as of the date of this press release and are advised to consider the factors listed above together with the additional factors under the heading “Forward-Looking Statements” and “Risk Factors” in red violet’s SEC Filings. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.

Investor Relations Contact:

Camilo Ramirez
Red Violet, Inc.
561-757-4500
[email protected]

FRAMINGHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) — Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of one senior leader, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare’s Board of Directors granted inducement awards. The Committee granted Jeff Moyer, Definitive Healthcare’s new SVP of Growth and Sales Operations, an inducement award consisting of 364,432 time-based restricted stock units (“RSUs”), effective April 3, 2025. These awards were individually negotiated and granted as an inducement material to Mr. Moyer’s respective commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).

Each of the awards is subject to the terms and conditions of Definitive Healthcare’s 2023 Inducement Plan (the “Plan”) and the terms and conditions of an applicable award agreement covering the grant.

Mr. Moyer’s RSUs will vest as follows, subject to Mr. Moyer’s continued employment through each such date: (i) 25% will vest on April 1, 2026; (ii) the remainder will vest in quarterly installments equal to 6.25% of the total RSUs over the subsequent 3 years, until fully vested.

About Definitive Healthcare

At Definitive Healthcare, our passion is to transform data, analytics, and expertise into healthcare commercial intelligence. We help clients uncover the right markets, opportunities, and people, so they can shape tomorrow’s healthcare industry. Our SaaS platform creates new paths to commercial success in the healthcare market, so companies can identify where to go next. Learn more at definitivehc.com.

Investor Contact:

Brian Denyeau
ICR for Definitive Healthcare
[email protected]
646-277-1251

Media Contact:

Bethany Swackhamer
[email protected]

HOUSTON, April 04, 2025 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) is excited to announce the grand opening of two new communities in the Houston area: Canterra Creek in Iowa Colony and Trails at Cochran Ranch in Waller. Both communities offer a selection of newly constructed homes with built-in upgrades, providing an affordable and convenient path to homeownership in desirable locations.

Canterra Creek – Iowa Colony, TX

Located just 15 miles from Pearland, Canterra Creek offers homebuyers a choice of spacious three- and four-bedroom homes, ranging from 1,375 to 2,339 square feet. With both one- and two-story floor plans available, each home comes with LGI Homes’ CompleteHome™ package, featuring a range of high-quality upgrades such as granite countertops, stainless steel Whirlpool® kitchen appliances, designer wood cabinetry, luxury vinyl-plank flooring and Wi-Fi-enabled garage door openers—all included in the base price.

Canterra Creek is designed with families in mind, offering a wealth of amenities for residents to enjoy. The community will feature a lazy river, multiple pools, splash pads, sports courts, and exercise facilities. Additionally, scenic walking trails provide residents with ample options for outdoor activities. Canterra Creek is also conveniently located near Highway 288, ensuring quick access to Houston’s major employers, shopping, dining and entertainment options.

“Minutes from the Med Center and Manvel Town Center, Canterra Creek offers incredible value,” stated Zach Walden, VP of Operations for Houston. “The community’s amenity center, slated to open this summer, includes a pool, pickleball courts and fitness center.”

Homes at Canterra Creek start in the $290s, with move-in ready homes available. To learn more or schedule a tour, interested buyers can call (866) 764-8973 ext. 350.

Trails at Cochran Ranch – Waller, TX

Located in Waller, Texas, Trails at Cochran Ranch offers affordable three- and four-bedroom homes designed with open-concept layouts. Each home comes with LGI Homes’ CompleteHome™ package, which includes upgrades like stainless steel kitchen appliances, granite countertops, luxury vinyl plank flooring, and energy-efficient windows included.

“With Waller being one of the fastest growing areas in metro Houston, we are excited to open Trails at Cochran Ranch offering affordable, new single-family homes on spacious lots,” stated Walden.

The community boasts a variety of family-friendly amenities, including a community park, playground, pavilion, and scenic walking trails. Trails at Cochran Ranch is situated near the heart of Waller, providing residents with proximity to local shopping, dining, and entertainment options, as well as excellent schools. With its welcoming neighborhood atmosphere, this community is perfect for families looking to settle in a well-connected area.

Homes at Trails at Cochran Ranch start from the low-$200s, with move-in ready opportunities available. For more information or to schedule a tour, interested buyers can call (855) 958-4517 ext. 350.

About LGI Homes

Headquartered in The Woodlands, Texas, LGI Homes, Inc. is a pioneer in the homebuilding industry, successfully applying an innovative and systematic approach to the design, construction and sale of homes across 36 markets in 21 states. As one of America’s fastest growing companies, LGI Homes has closed over 75,000 homes since its founding in 2003 and has delivered profitable financial results every year. Nationally recognized for its quality construction and exceptional customer service, LGI Homes was named to Newsweek’s list of the World’s Most Trustworthy Companies. LGI Homes’ commitment to excellence extends to its more than 1,000 employees, earning the Company numerous workplace awards at the local, state and national level, including the Top Workplaces USA 2024 Award. For more information about LGI Homes and its unique operating model focused on making the dream of homeownership a reality for families across the nation, please visit the Company’s website at www.lgihomes.com.

MEDIA CONTACT:

Rachel Eaton
(281) 362-8998 ext. 2560

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/9632bdd3-c7e8-4fa4-af24-37e506df0844

WAYNE, Pa., April 04, 2025 (GLOBE NEWSWIRE) — (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no Food and Drug Administration (FDA)-approved therapies, today announced that Wes Kaupinen, Founder and Chief Executive Officer of Palvella will participate in a fireside chat at the Jones Healthcare and Technology Innovation Conference on Wednesday, April 9, 2025, at 2:00 p.m. PT.

A live webcast of the fireside chat will be available on the Events and Presentations section of Palvella’s website at www.palvellatx.com. An archived replay of the webcast will be available for approximately 90 days following the presentation.

About Palvella Therapeutics

Founded and led by rare disease drug development veterans, Palvella Therapeutics, Inc. (Nasdaq: PVLA) is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. Palvella is developing a broad pipeline of product candidates based on its patented QTORIN™ platform, with an initial focus on serious, rare genetic skin diseases, many of which are lifelong in nature. Palvella’s lead product candidate, QTORIN 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin), is currently being evaluated in the Phase 3 SELVA clinical trial in microcystic lymphatic malformations and the Phase 2 TOIVA clinical trial in cutaneous venous malformations. For more information, please visit www.palvellatx.com or follow Palvella on LinkedIn or X (formerly known as Twitter).

QTORIN™ rapamycin is for investigational use only and has not been approved or cleared by the FDA or by any other regulatory agency for any indication.

Contact Information

Investors

Wesley H. Kaupinen
Founder and CEO, Palvella Therapeutics
[email protected]

Media

Marcy Nanus
Managing Partner, Trilon Advisors, LLC
[email protected]

MIAMI, April 04, 2025 (GLOBE NEWSWIRE) — OPKOHealth,Inc.(NASDAQ:OPK) today announced that its Board of Directors has authorized an increase of $100 million to the Company’s existing common stock repurchase program, bringing the aggregate capacity of the program to $200 million. Approximately $41 million of OPKO’s common stock has been repurchased under the existing program since its authorization in July 2024.

“We believe OPKO’s shares continue to be significantly undervalued and offer an attractive investment opportunity. Buying back shares supports our conviction in OPKO’s strategy as we continue to advance our pipeline in the clinic and streamline our diagnostic segment on a path to profitability,” said Phillip Frost, M.D., Chairman and Chief Executive Officer of OPKO. “Our strong cash position provides the ability to continue to fund our programs, while returning capital to our shareholders.”

OPKO intends to repurchase shares of its common stock from time to time through open market purchases, block trades, privately negotiated transactions, accelerated share repurchase transactions and/or pursuant to Rule 10b5-1 plans, in compliance with applicable securities laws and other legal requirements. The timing and amount of any repurchases will be subject to general market conditions, as well as the Company’s management of capital, other investment opportunities and other factors. The repurchase program does not obligate the Company to repurchase any specific number of shares, has no time limit and may be modified, suspended or discontinued at any time at the Company’s discretion.

OPKO currently expects to fund the repurchase program from existing cash and cash equivalents, and future cash flows. The Company had approximately 671.6 million shares outstanding as of February 24, 2025.   This increased authorization, along with the prior authorization, represents approximately 14% of shares outstanding at the current stock price.

About
OPKO
Health

OPKO Health is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development and commercialization expertise, and its novel and proprietary technologies. For more information, visit www.opko.com.

Cautionary
Statement
Regarding
Forward
Looking
Statements

This
press
release
contains
“forward-looking
statements,”
as
that
term
is
defined
under
the
Private
Securities
Litigation
Reform
Act
of
1995
(“PSLRA”),
including,
among
other
things,
statements
related
to
expected
purchases
under
the
Repurchase
Program.
These
forward-
looking
statements
may
be
identified
by
words
such
as
“expects,”
“plans,”
“projects,”
“will,”
“may,”
“anticipates,”
“believes,”
“should,”
“intends,”
“estimates,”
and
other
words
of
similar
meaning.
These
statements
are
based
on
management’s
current
expectations
and
are subject
to
uncertainty
and
changes
in
circumstances.
Many
factors
could
cause
the
Company’s
actual
activities
or
results
to
differ
materially
from
the
activities
and
results
anticipated
in
forward-looking
statements.
These
factors
include
those
described
in
the
Company’s
Annual
Reports
on
Form
10-K
filed
and
to
be
filed
with
the
Securities
and
Exchange
Commission
and
under
the
heading
“Risk
Factors”
in
the
Company’s
other
filings
with
the
Securities
and
Exchange
Commission.
In
addition,
forward-looking
statements
may
also
be
adversely
affected
by
general
market
factors,
competitive
product
development,
product
availability,
federal
and
state
regulations
and
legislation,
the
regulatory
process
for
new
products
and
indications,
manufacturing
issues
that
may
arise,
patent
positions
and
litigation, among
other factors. The
forward-looking
statements
contained
in
this
press
release
speak
only
as
of
the
date
the
statements
were
made,
and
the
Company
does
not
undertake
any
obligation
to
update
forward-looking
statements.
The
Company
intends
that
all
forward-looking
statements
be
subject
to
the
safe-harbor
provisions
of
the
PSLRA.

Contacts:

Alliance Advisors IR

Yvonne Briggs, 310-691-7100
[email protected]
or
Bruce Voss, 310-691-7100
[email protected]

PHILADELPHIA, April 04, 2025 (GLOBE NEWSWIRE) — Carpenter Technology Corporation (NYSE: CRS) plans to host a conference call and webcast on Thursday, April 24, 2025 at 10:00 a.m. ET to discuss the results of operations for the third quarter of fiscal year 2025, ended March 31, 2025. The call and webcast will follow the release of third quarter fiscal 2025 financial results before the market opens on Thursday, April 24, 2025.

Conference Call and Webcast Details

What: Carpenter Technology Third Quarter Fiscal 2025 Conference Call

Date: Thursday April 24, 2025

Time: 10:00 a.m. Eastern Time

Live and Archived Webcast: ir.carpentertechnology.com

About Carpenter Technology

Carpenter Technology Corporation is a recognized leader in high-performance specialty alloy materials and process solutions for critical applications in the aerospace and defense, medical, transportation, energy, and industrial and consumer markets. Founded in 1889, Carpenter Technology has evolved to become a pioneer in premium specialty alloys including nickel, cobalt, and titanium and material process capabilities that solve our customers’ current and future material challenges. More information about Carpenter Technology can be found at www.carpentertechnology.com.

Investor Inquiries:		Media Inquiries:
John Huyette		Heather Beardsley
+1 610-208-2061		+1 610-208-2278
[email protected]		[email protected]

                                                                
                                                                             
                                                               
                                                              

AUSTIN, Texas, April 04, 2025 (GLOBE NEWSWIRE) — Mondee Holdings, Inc. announces its acquisition by Tabhi, and exit from Chapter 11 restructuring. Tabhi acquired substantially all the assets of Mondee Holdings, Inc. and strengthened its balance sheet by investing additional equity, significantly reducing debt and other obligations.

Tabhi ownership includes affiliates of TCW Asset Management Company LLC (“TCW”), Morgan Stanley Investment Management (“MSIM”), and Prasad Gundumogula, the Company’s Co-Founder and Chairman. With a substantial personal cash investment, Mr. Gundumogula now holds a majority equity stake and has stepped in as the company’s CEO. TCW is also the Administrative Agent on a new credit facility that includes MSIM and Wingspire Capital LLC.

“The company is on stronger footing as we cut debt roughly in half, raised new cash equity, and have partnered with leading financial institutions,” said Mr. Gundumogula. “Now operating as Tabhi, the company is in a more stable financial and operational position to continue its prior growth as a leader in travel services and technology.”

Mr. Gundumogula continues, “We provide travel technology and privately negotiated airline and hotel content to over 65,000 travel experts and organizations who service over 125 million global travelers. The company was the first to introduce cutting edge AI in travel and we expect to continue to innovate and transform the industry with our AI solutions. With offices spanning four continents, we connect citizens of the world.”

About Mondee:

Established in 2011, Mondee is a leading travel marketplace and artificial intelligence (AI) technology company with its headquarters based in Austin, Texas. The Company operates 21 offices globally across the United States and Canada, Brazil, Mexico, India, and Greece. Mondee is driving change in the leisure and corporate travel sectors through its broad array of innovative solutions. Available both as an app and through the web, the Company’s platform processes over 50 million daily searches and generates a substantial transactional volume annually. Mondee Marketplace includes access to Abhi, one of the most powerful and fully integrated AI travel planning assistants in the market. Mondee’s network and marketplace include approximately 65,000 travel experts, 500+ airlines, and over one million hotels and vacation rentals, 30,000 rental car pickup locations, and 50+ cruise lines. The Company also offers packaged solutions and ancillary offerings that serve its global distribution. For further information, visit: www.mondee.com.

For Further Information, Contact:
Public Relations
[email protected]

EL SEGUNDO, Calif., April 04, 2025 (GLOBE NEWSWIRE) — A-Mark Precious Metals,Inc.(NASDAQ: AMRK) (A-Mark), a leading fully integrated precious metals platform, today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, maintaining the company’s current dividend program. The dividend is payable on April 29, 2025, to stockholders of record as of April 15, 2025.  

On April 1, 2025, A-Mark completed the acquisition of the 90% of AMS Holding, LLC (AMS) not previously owned by A-Mark. Founded in 1984, AMS operates the flagship brand GOVMINT where a team of over 150 dedicated sales representatives works with customers to assemble collections of vintage and modern coins. AMS generated Total Revenue of $203.8 million and Adjusted EBITDA of $9.3 million during the year ended December 31, 2024.

About A-Mark Precious Metals

Founded in 1965, A-Mark Precious Metals, Inc. is a leading fully integrated precious metals platform that offers an array of gold, silver, platinum, palladium, and copper bullion, numismatic coins, and related products to wholesale and retail customers via a portfolio of channels. The company conducts its operations through three complementary segments: Wholesale Sales & Ancillary Services, Direct-to-Consumer, and Secured Lending. The company’s global customer base spans sovereign and private mints, manufacturers and fabricators, refiners, dealers, financial institutions, industrial users, investors, collectors, e-commerce customers, and other retail customers.

A-Mark’s Wholesale Sales & Ancillary Services segment distributes and purchases precious metal products from sovereign and private mints. As a U.S. Mint-authorized purchaser of gold, silver, and platinum coins since 1986, A-Mark purchases bullion products directly from the U.S. Mint for sale to customers. A-Mark also has longstanding distributorships with other sovereign mints, including Australia, Austria, Canada, China, Mexico, South Africa, and the United Kingdom. The company sells more than 200 different products to e-commerce retailers, coin and bullion dealers, financial institutions, brokerages, and collectors. In addition, A-Mark sells precious metal products to industrial users, including metal refiners, manufacturers, and electronic fabricators.

A-Mark’s consolidated subsidiary, Stack’s Bowers Galleries is a rare coin and currency auction house as well as a wholesale and retail dealer of numismatic and bullion products. Pinehurst Coin Exchange is a precious metals broker that services the wholesale and retail marketplace and is retailer of modern and numismatic coins on eBay.

LPM Group Limited (LPM), is one of Asia’s largest precious metals dealers. LPM operates a consumer-facing showroom in Hong Kong’s Central Financial District, and offers a wide selection of products to its wholesale customers through its 24/7 online trading platform, including recently released silver coins, gold bullion, certified coins, and the latest collectible numismatic issues.

Through its A-M Global Logistics subsidiary, A-Mark provides its customers with a range of complementary services, including managed storage options for precious metals as well as receiving, handling, inventorying, processing, packaging, and shipping of precious metals and coins on a secure basis. A-Mark’s mint operations, which are conducted through its wholly owned subsidiary Silver Towne Mint, enable the company to offer customers a wide range of proprietary coin and bar offerings and, during periods of market volatility when the availability of silver bullion from sovereign mints is often product constrained, preferred product access.

A-Mark’s Direct-to-Consumer segment operates as an omni-channel retailer of precious metals, providing access to a multitude of products through its wholly owned subsidiaries, JM Bullion, Goldline, AMS, and Silver Gold Bull. JMB owns and operates numerous websites targeting specific niches within the precious metals retail market, including JMBullion.com, ProvidentMetals.com, Silver.com, CyberMetals.com, GoldPrice.org, SilverPrice.org, BGASC.com, BullionMax.com, and Gold.com. Goldline markets precious metals directly to the investor community through various channels, including television, radio, and telephonic sales efforts. AMS operates GOVMINT, which markets vintage and modern coins through channels that include a dedicated website, television advertising, and telephonic sales efforts. A-Mark is the majority owner of Silver Gold Bull, a leading online precious metals retailer in Canada, and also holds minority ownership interests in two additional direct-to-consumer brands.

The company operates its Secured Lending segment through its wholly owned subsidiary, Collateral Finance Corporation (CFC). Founded in 2005, CFC is a California licensed finance lender that originates and acquires loans secured by bullion and numismatic coins. Its customers include coin and precious metal dealers, investors, and collectors.

A-Mark is headquartered in El Segundo, CA and has additional offices and facilities in the neighboring Los Angeles area as well as in Dallas, TX, Las Vegas, NV, Winchester, IN, Vienna, Austria, and Hong Kong. For more information, visit www.amark.com.

A-Mark periodically provides information for investors on its corporate website, www.amark.com, and its investor relations website, ir.amark.com. This includes press releases and other information about financial performance, reports filed or furnished with the SEC, information on corporate governance, and investor presentations.

Important Cautions Regarding Forward-Looking Statements

Statements in this press release that relate to future plans, objectives, expectations, performance, events and the like are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and the Securities Exchange Act of 1934. These include statements relating to expectations regarding the dividend declaration and the amount or timing of any future dividends. Future events, risks and uncertainties, individually or in the aggregate, could cause actual results or circumstances to differ materially from those expressed or implied in these statements. Factors that could cause actual results to differ include the following: the failure to execute the Company’s growth strategy, including the inability to identify suitable or available acquisition or investment opportunities; greater than anticipated costs incurred to execute this strategy; government regulations that might impede growth, particularly in Asia; the inability to successfully integrate recently acquired businesses; changes in the current international political climate, which historically has favorably contributed to demand and volatility in the precious metals markets but also has posed certain risks and uncertainties for the Company, particularly in recent periods; potential adverse effects of the current problems in the national and global supply chains; the impact that the recently announced tariffs and other trade restrictions may have on our business; increased competition for the Company’s higher margin services, which could depress pricing; the failure of the Company’s business model to respond to changes in the market environment as anticipated; changes in consumer demand and preferences for precious metal products generally; potential negative effects that inflationary pressure may have on our business; the inability of the Company to expand capacity at Silver Towne Mint; the failure of our investee companies to maintain, or address the preferences of, their customer bases; general risks of doing business in the commodity markets; and the strategic, business, economic, financial, political and governmental risks and other Risk Factors described in in the Company’s public filings with the Securities and Exchange Commission.

The Company undertakes no obligation to publicly update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements.

Company Contact:

Steve Reiner, Executive Vice President, Capital Markets & Investor Relations
A-Mark Precious Metals, Inc.
1-310-587-1410
[email protected]

Investor Relations Contact:

Matt Glover, Greg Bradbury
Gateway Group, Inc.
1-949-574-3860
[email protected]

NEW ALBANY, Ohio, April 04, 2025 (GLOBE NEWSWIRE) — Commercial Vehicle Group, Inc. (the “Company” or “CVG”) announced the retirement of Robert C. Griffin, from the Board of Directors of the Company, effective May 15, 2025, without standing for re-election at the 2025 annual meeting of stockholders.

Mr. Griffin has served as a Director since 2005 and is the current Chairman of the Board. Mr. Griffin’s retirement is not as a result of any disagreement with the Company, its management, the Board or any committee of the Board. It is expected that William C. Johnson will serve as the Chairman of the Board following Mr. Griffin’s retirement.

The Chairman of the Nominating, Governance and Sustainability Committee, Michael Nauman, thanked Mr. Griffin for his service and leadership on the Board. “Bob has been an invaluable contributor to the Board since the Company’s earliest days and provided extraordinary leadership to the Board and the Company during his tenure. On behalf of the entire Board of Directors, I want to express my appreciation for Bob’s contributions as we worked together to support the Company’s strategic goals and priorities.”

Mr. Griffin said, “It has been a privilege to serve the shareholders of CVG for 20 years. It has been gratifying to work with the Board and management at CVG and I look forward to following their future success.” He added, ” I wish my fellow directors, and CVG the very best.”

Company Contact

Andy Cheung
Chief Financial Officer
CVG
[email protected]

Investor Relations Contact

Ross Collins or Stephen Poe
Alpha IR Group
[email protected]

About CVG

At CVG, we deliver real solutions to complex design, engineering and manufacturing problems while creating positive change for our customers, industries and communities we serve. Information about the Company and its products is available on the internet at www.cvgrp.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. For this purpose, any statements contained herein that are not statements of historical fact, including without limitation, certain statements herein regarding industry outlook, the Company’s expectations for future periods with respect to its plans to improve financial results, the future of the Company’s end markets changes in the Class 8 and Class 5-7 North America truck build rates, performance of the global construction and agricultural equipment business, the Company’s prospects in the wire harness and electric vehicle markets, the Company’s initiatives to address customer needs, organic growth, the Company’s strategic plans and plans to focus on certain segments, competition faced by the Company, volatility in and disruption to the global economic environment, including global supply chain constraints, inflation and labor shortages, tariffs and counter-measures, financial covenant compliance, anticipated effects of acquisitions or divestitures, production of new products, plans for capital expenditures and our results of operations or financial position and liquidity, may be deemed to be forward-looking statements. Without limiting the foregoing, the words “believe”, “anticipate”, “plan”, “expect”, “intend”, “will”, “should”, “could”, “would”, “project”, “continue”, “likely”, and similar expressions, as they relate to us, are intended to identify forward-looking statements. The important factors discussed in “Item 1A – Risk Factors” in the Company’s Annual Report on Form 10-K, among others, could cause actual results to differ materially from those indicated by forward-looking statements made herein and presented elsewhere by management from time to time. Such forward-looking statements represent management’s current expectations and are inherently uncertain. Investors are warned that actual results may differ from management’s expectations. Additionally, various economic and competitive factors could cause actual results to differ materially from those discussed in such forward-looking statements, including, but not limited to, factors which are outside our control.

Any forward-looking statement that we make in this press release speaks only as of the date of such statement, and we undertake no obligation to update any forward-looking statement or to publicly announce the results of any revision to any of those statements to reflect future events or developments. Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance, unless specifically expressed as such, and should only be viewed as historical data.

Innovative Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Pacemakers and Neurostimulators Earns Bronze in Post-Surgical Recovery Solutions Category

SILVER SPRING, Md., April 04, 2025 (GLOBE NEWSWIRE) — Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that EluPro™, the first ever FDA-cleared antibiotic-eluting bioenvelope was honored with a 2025 Bronze Edison Award™ for its innovative approach to reducing post-surgical complications. The 2025 finalists were selected from thousands of submissions, rigorously evaluated on concept, value, delivery, and impact. The selection process was led by the Edison Awards Steering Committee and an independent panel of experts, including scientists, engineers, designers, and business leaders.

“It’s an incredible honor to accept this award on behalf of Elutia and to see EluPro recognized alongside some of the most innovative products in the world,” said Dr. Randy Mills, CEO of Elutia. “This isn’t just a prestigious award—it’s a reflection of our team’s ridiculously relentless commitment to solving real problems for real people. I’m proud of the Elutia CRU for pushing boundaries every day so patients everywhere can thrive without compromise. Congratulations to the entire team!”

Launched in January 2025, EluPro is cleared for use across all major cardiac implanted electronic device (CIED) products including pacemakers and implantable defibrillators, as well as for neurostimulation devices. Unlike synthetic alternatives, EluPro combines a soft, regenerative biomatrix with the trusted antibiotics rifampin and minocycline to address CIED complications and support healthy healing. With more than 600,000 CIEDs implanted annually in the U.S. and complications—such as infection, migration, and skin erosion—occurring in up to 5-7% of cases, the need for improved outcomes is clear. EluPro provides a comprehensive solution for both patients and clinicians.

The 2025 Edison Awards were presented on Thursday, April 3 at the Luminary Hotel and the Caloosa Sound Convention Center in Fort Myers, Florida.

To learn more, visit www.elutia.com/products/elupro/.

About Elutia

Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.

About the Edison Awards™
Established in 1987, the Edison Awards are dedicated to recognizing, honoring and fostering innovations and innovators. Named after Thomas Alva Edison (1847-1931), the annual competition honors excellence in new product and service development, marketing, design and innovation. For more information visit www.edisonawards.com.

Forward Looking Statements
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can be identified by words such as “projects,” “may,” “will,” “could,” “would,” “should,” “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “potential,” “promise” or similar references to future periods. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements. Forward-looking statements contained in this press release include, without limitation, any statements we make regarding the potential for EluPro to represent a meaningful step forward in CIED antibiotic envelope technology. These forward-looking statements are based on our management’s beliefs and assumptions and on information currently available to us. Such beliefs and assumptions may or may not prove to be correct. Additionally, such forward-looking statements are subject to a number of known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied in the forward-looking statements, including, but not limited to the following: the risk that clinical research data may not match preclinical study data; our ability to successfully commercialize, market and sell our EluPro product; our ability to continue as a going concern; our ability to achieve or sustain profitability; the risk of product liability claims and our ability to obtain or maintain adequate product liability insurance; our ability to defend against the various lawsuits and claims related to our recalled FiberCel and other viable bone matrix products and avoid a material adverse financial consequence from those lawsuits and claims; our ability to prevail in lawsuits and claims seeking indemnity, contribution and insurance coverage for FiberCel and other viable bone matrix product liabilities; the continued and future acceptance of our products by the medical community; our ability to enhance our products, expand our product indications and develop, acquire and commercialize additional product offerings; our dependence on our commercial partners and independent sales agents to generate a substantial portion of our net sales; our dependence on a limited number of third-party suppliers and manufacturers, which, in certain cases are exclusive suppliers for products essential to our business; our ability to successfully realize the anticipated benefits of the sale of our Orthobiologics business; physician awareness of the distinctive characteristics, benefits, safety, clinical efficacy and cost-effectiveness of our products; our ability to compete against other companies, most of which have longer operating histories, more established products and/or greater resources than we do; pricing pressure as a result of cost-containment efforts of our customers, purchasing groups, third-party payors and governmental organizations could adversely affect our sales and profitability; our ability to obtain regulatory approval or other marketing authorizations by the FDA and comparable foreign authorities for our products and product candidates; our ability to obtain, maintain and adequately protect our intellectual property rights; and other important factors which can be found in the “Risk Factors” section of Elutia’s public filings with the Securities and Exchange Commission (“SEC”), including Elutia’s Annual Report on Form 10-K for the year ended December 31, 2024, as such factors may be updated from time to time in Elutia’s other filings with the SEC, accessible on the SEC’s website at www.sec.gov and the Investor Relations page of Elutia’s website at https://investors.elutia.com. Because forward-looking statements are inherently subject to risks and uncertainties, you should not rely on these forward-looking statements as predictions of future events. Any forward-looking statement made by Elutia in this press release is based only on information currently available and speaks only as of the date on which it is made. Except as required by applicable law, Elutia expressly disclaims any obligations to publicly update any forward-looking statements, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Investors:

Matt Steinberg
FINN Partners
[email protected]

This press release was published by a CLEAR® Verified individual.